What starting dose of escitalopram should I use when switching from sertraline 100 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Starting Dose of Escitalopram When Switching from Sertraline 100 mg

Start escitalopram at 10 mg once daily when discontinuing sertraline 100 mg. This is the standard FDA-approved starting dose for adults and represents the appropriate therapeutic equivalent based on dose-equivalence data 1.

Rationale for 10 mg Starting Dose

The FDA label for escitalopram clearly states that 10 mg once daily is the recommended starting dose for adults with major depressive disorder 1. This dose has demonstrated effectiveness in clinical trials and should not be adjusted based on the previous sertraline dose, as you are initiating a new medication rather than performing a direct dose conversion.

Dose equivalence research supports this approach: When comparing antidepressant doses, sertraline 100 mg is approximately equivalent to escitalopram 18 mg based on systematic analysis of randomized controlled trials 2. However, this does not mean you should start at 18 mg—the standard starting dose of 10 mg remains appropriate because:

  • Starting at therapeutic doses minimizes initial side effects like anxiety or agitation, which are common early SSRI adverse effects 3
  • The 10 mg dose is effective for most patients with moderate depression 4
  • Dose can be increased to 20 mg after a minimum of one week if needed 1

How to Manage the Transition

Discontinuation of Sertraline

Taper sertraline gradually rather than stopping abruptly to minimize discontinuation syndrome. Sertraline is associated with discontinuation symptoms including dizziness, fatigue, nausea, sensory disturbances, and anxiety 3. The guidelines recommend tapering over 10-14 days when discontinuing antidepressants 5.

Timing of Escitalopram Initiation

You can use either a direct switch or cross-taper approach:

  • Direct switch: Taper sertraline over 1-2 weeks, then start escitalopram 10 mg the day after sertraline is stopped
  • Cross-taper: Begin escitalopram 10 mg while simultaneously tapering sertraline (start escitalopram at a low dose, increase slowly while decreasing sertraline)

Important safety consideration: When combining two SSRIs during cross-taper, start the second medication at a low dose and monitor closely for serotonin syndrome, especially in the first 24-48 hours after dosage changes 3. However, the risk is relatively low when switching between SSRIs (as opposed to combining with MAOIs or multiple serotonergic agents).

Dose Titration Strategy

  • Start: Escitalopram 10 mg once daily (morning or evening, with or without food) 1
  • Assess response: After 1-2 weeks at 10 mg
  • Increase if needed: To 20 mg once daily after a minimum of 1 week if inadequate response 1
  • Maximum dose: 20 mg daily for most adults; 10 mg daily for elderly patients or those with hepatic impairment 1

Clinical Monitoring

Monitor for:

  • Discontinuation symptoms from sertraline (first 1-2 weeks)
  • Early SSRI side effects from escitalopram (anxiety, agitation, GI symptoms, insomnia)
  • Serotonin syndrome if cross-tapering (confusion, agitation, tremors, hyperreflexia, tachycardia, diaphoresis) 3
  • Therapeutic response using standardized rating scales at 1-2 week intervals 3

Special Populations

  • Elderly patients: Start at 10 mg daily (this is also the maximum recommended dose) 1
  • Hepatic impairment: 10 mg daily is the recommended dose 1
  • Renal impairment: No adjustment needed for mild-moderate; use caution in severe impairment 1

Key Advantages of Escitalopram

Escitalopram has the least effect on CYP450 enzymes compared to other SSRIs, resulting in lower propensity for drug-drug interactions 3. This makes it a favorable choice when switching from sertraline, particularly in patients on multiple medications.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.